Glen Hawthorne

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper

Giuditta Illuzzi, Anna D. Staniszewska, Sonja J. Gill et al. · Clinical Cancer Research · 2022 · 171 citations · Full text

Medicine, Oncology, Pharmacology +13

Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1

Anna D. Staniszewska, Domenic Pilger, Sonja J. Gill et al. · Clinical Cancer Research · 2023 · 58 citations

Medicine, Oncology, Pharmacology +14

Abstract LB-273: A head-to-head comparison of the properties of five clinical PARP inhibitors identifies new insights that can explain both the observed clinical efficacy and safety profiles

Elisabetta Leo, Jeffrey W. Johannes, Giuditta Illuzzi et al. · Cancer Research · 2018 · 23 citations

Medicine, Oncology, Pharmacology +16

Feedback from the European Bioanalysis Forum Liquid Microsampling Consortium: Microsampling: Assessing Accuracy and Precision of Handheld Pipettes and Capillaries

Glen Hawthorne, Lieve Dillen, Matthew Barfield et al. · Bioanalysis · 2019 · 13 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +12

European Bioanalysis Forum Continued Plans to Support Liquid Microsampling

Philip Timmerman, Steve White, Zoe Cobb et al. · Bioanalysis · 2014 · 12 citations

Natural Sciences, Biomedical Engineering, Analytical Chemistry +4